Evidence map›Paper›PMID 32589632›Full record

Trial reportPLoS neglected tropical diseases2020

A randomized controlled trial comparing the effectiveness of individual versus household treatment for Scabies in Lambaréné, Gabon.

Julian Matthewman, Rella Zoleko Manego, Lia Betty Dimessa Mbadinga, Hana Šinkovec, Katrin Völker, Malik Akinosho, Christian Haedrich, Jeanne Tardif d'Hamonville, Bertrand Lell, Ayola Akim Adegnika and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Julian MatthewmanCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.ORCID 0000-0003-3291-2381
Rella Zoleko ManegoCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Lia Betty Dimessa MbadingaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Hana ŠinkovecCenter for Medical Statistics, Informatics and Intelligent Systems, Institute of Clinical Biometrics, Medical University of Vienna, Vienna, Austria.
Katrin VölkerDepartment of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, & I Dep. of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Malik AkinoshoCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Christian HaedrichCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Jeanne Tardif d'HamonvilleCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Bertrand LellCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.ORCID 0000-0003-1427-3002
Ayola Akim AdegnikaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Michael RamharterCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Ghyslain Mombo-NgomaCentre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is unclear whether individual treatment of scabies is similarly effective compared to household treatment. This study compared these two treatment strategies with topical benzyl benzoate for treating scabies in Lambaréné, Gabon.

methodsParticipants presenting with uncomplicated scabies were randomized into either the Individual Treatment group, where only the affected participants received treatment, or the Household Treatment group, where all family members were treated in parallel to the affected participants regardless of signs and symptoms. The primary endpoint was clinical cure after 28 days; the secondary endpoint was the proportion of affected household members per household after 28 days.

resultsAfter 28 days, from a total of 79 participants assessed, 67% (n = 53) were clinically cured; 59% (20/34) in the Individual Treatment group and 73% (33/45) in the Household Treatment group. Participants in the Household Treatment group had about twice the odds of being cured (odds ratio 1.9, 95% confidence interval: 0.8-4.9; p = 0.17). For the secondary outcome, an effect of similar size was observed.

conclusionsOur findings show that treating close contacts of persons affected by scabies may be beneficial to patients and contacts, however, the benefit was less pronounced than anticipated and further research is needed to definitively answer this question.

Indexed as

Family CharacteristicsAdolescentAdultBenzoatesChildChild, PreschoolFemaleGabonHumansInfantInsecticidesMaleMiddle AgedScabiesYoung AdultBenzoatesbenzyl benzoateInsecticides

Identifiers

PMID32589632
PMCPMC7347237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.